Overseas Regulatory Announcement - Announcement in Relation to the Receipt of Clinical Trial Application Acceptance by a Subsidiary
(WorldNews Germany)

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. ɪऎూ݋ᔼᖹ€ණྠٰ΅Ϟࠢʮ̡ Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* (a joint stock limited company incorporated in the People`s Republic of China with limited liability) (Stock Code: 02196) OVERSEAS REGULATORY ANNOUNCEMENT This announcement is made pursuant to Rule 13.10B of the Rules Governing the Listing of Securities on The Stock...